piracetam has been researched along with Psychomotor Agitation in 3 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Psychomotor Agitation: A feeling of restlessness associated with increased motor activity. This may occur as a manifestation of nervous system drug toxicity or other conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy and safety of 3,000 mg daily levetiracetam (LEV; Keppra) as an adjunctive therapy for Chinese patients with refractory partial seizures." | 9.14 | Efficacy and safety of levetiracetam (3,000 mg/Day) as an adjunctive therapy in Chinese patients with refractory partial seizures. ( Li, JM; Lv, Y; Sun, HB; Wang, XF; Xi, ZQ; Xiao, F; Xiao, Z, 2009) |
| " Therefore, it was of interest to assess the efficacy of piracetam, a positive modulator of AMPA-sensitive glutamate receptors in autistic disorder." | 9.13 | A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder. ( Akhondzadeh, S; Ghelichnia, HA; Mohammadi, M; Mohammadi, MR; Nouroozinejad, GH; Shabstari, OL; Tajdar, H, 2008) |
| "To evaluate the efficacy and safety of 3,000 mg daily levetiracetam (LEV; Keppra) as an adjunctive therapy for Chinese patients with refractory partial seizures." | 5.14 | Efficacy and safety of levetiracetam (3,000 mg/Day) as an adjunctive therapy in Chinese patients with refractory partial seizures. ( Li, JM; Lv, Y; Sun, HB; Wang, XF; Xi, ZQ; Xiao, F; Xiao, Z, 2009) |
| " Therefore, it was of interest to assess the efficacy of piracetam, a positive modulator of AMPA-sensitive glutamate receptors in autistic disorder." | 5.13 | A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder. ( Akhondzadeh, S; Ghelichnia, HA; Mohammadi, M; Mohammadi, MR; Nouroozinejad, GH; Shabstari, OL; Tajdar, H, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xiao, Z | 1 |
| Li, JM | 1 |
| Wang, XF | 1 |
| Xiao, F | 1 |
| Xi, ZQ | 1 |
| Lv, Y | 1 |
| Sun, HB | 1 |
| Siniscalchi, A | 1 |
| Gallelli, L | 1 |
| De Fazio, S | 1 |
| De Sarro, G | 1 |
| Akhondzadeh, S | 1 |
| Tajdar, H | 1 |
| Mohammadi, MR | 1 |
| Mohammadi, M | 1 |
| Nouroozinejad, GH | 1 |
| Shabstari, OL | 1 |
| Ghelichnia, HA | 1 |
2 trials available for piracetam and Psychomotor Agitation
| Article | Year |
|---|---|
Efficacy and safety of levetiracetam (3,000 mg/Day) as an adjunctive therapy in Chinese patients with refractory partial seizures.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Anticonvulsants; Body Weight; Chemotherapy, Adjuvant; | 2009 |
A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder.
Topics: Antipsychotic Agents; Autistic Disorder; Child; Child, Preschool; Diagnostic and Statistical Manual | 2008 |
1 other study available for piracetam and Psychomotor Agitation
| Article | Year |
|---|---|
Psychic disturbances associated with sodium valproate plus levetiracetam.
Topics: Anticonvulsants; Anxiety; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Levetirace | 2007 |